Luna DNA is the founder and manager of the first community owned genomic and health research platform.

Incentivizing the Sharing of Health & DNA Data

The community owned platform rewards people for sharing the data they already own, contributing to health research and discoveries that save lives.

Creating Big Data

As the health and DNA data platform grows, it will become increasingly valuable to the entire health research industry.

Health & DNA data has become siloed

As personal DNA sequencing has risen in popularity, the data has become siloed as each company looks to maximize their individual profit from this data.

There is currently little incentive for consumers to contribute their health and DNA data to a third party database.

There are also multiple privacy, security, and trust issues that limit broad participation.

The solution

Luna DNA founded and manages a community owned data platform that rewards individuals shares in the platform for contributing their DNA data and other medical information. Shares entitle members to a share in the proceeds from health research and discoveries. The proceeds flow back to the community as dividends as researchers pay to access the data for discovery.

The Team Leading Luna DNA

The Luna DNA team combines a deep background in medicine, DNA sequencing, big data, and large scale Internet communities.

Backgrounds From:

Bob Kain

CEO & Co-Founder

Bob Kain is a renowned pioneer in genomics. At Illumina, Bob led the invention of the modern, high throughput genome sequencer that brought the cost from millions of dollars down to less than $1000.

He joined Illumina pre-IPO in 1999 and retired in 2014, as the Chief Engineering Officer. Bob is lead inventor on 28 U.S. patents that led to the breakthroughs that have revolutionized genome sequencing. Prior to joining Illumina, Bob was the Director of the Microarray Business Unit at Molecular Dynamics. He is also on the Scientific Advisory Boards of Dovetail Genomics, Singular Genomics, and Edenroc Biosecurity, and is the co-founder of Revere Biosensor. Additionally, he is the co-founder and chairman of the board of a successful health & fitness business, Mesa Rim Climbing and Fitness Center, with multiple locations in San Diego and Reno, Nevada.

Bob received a BS in Physics from San Diego State University and an MBA from Saint Mary’s College of California.

Dawn Barry

President & Co-Founder

Dawn served as the Vice President of Applied Genomics at Illumina, Inc. Dawn integrated market development strategies with product and business model innovation to accelerate the application of genomics in medicine and personal healthcare. Dawn joined Illumina in 2005.

Prior to Illumina, Dawn spent seven years at Genaissance Pharmaceuticals, one of the first genomics startups focused on individualized medicine and DNA-based diagnostic testing.

She holds a BS in biology from the University of Vermont and a MBA from the University of Connecticut School of Business.

Scott Kahn, Ph.D

Scott Kahn, Ph.D

Chief Information Officer, Former CIO and VP of Commercial and Enterprise Informatics at Illumina

Luna DNA LinkedIn
David Lewis

David Lewis

CFO & Co-Founder, Chief Investment Officer & Co-Founder at Ganley Investments, Former Citigroup Executive

Luna DNA LinkedIn
Aaron Mendes

Aaron Mendes

VP Marketing, Former VP at 1010data, CEO at Quantio, CMO at Wellness.com

Luna DNA LinkedIn
Deborah Thompson

Debora Thompson

Vice President, Strategy & Business Operations, Former Director, Market Strategy and Innovation, Clinical Genomics at Illumina

Luna DNA LinkedIn
Kirby Bloom

Kirby Bloom

Chief Architect, Former Head of Software & Informatics, Applied Genomics at Illumina

Luna DNA LinkedIn
Bojil Velinov

Bojil Velinov

Head of Dev Ops & Automation, Former Sr. DevOps Architect, Clinical Genomics at Illumina

Luna DNA LinkedIn
Dan Lin

Dan Lin

Co-Founder, CTO & Co-Founder of Redemption Games, Blockchain Developer and Y Combinator Alumni

Luna DNA LinkedIn
Michael Witz

Michael Witz

Co-Founder, Co-Founder Redemption Games, Blockchain Investor and Y Combinator Alumni

Luna DNA LinkedIn
Ashley Van Zeeland, Ph.D

Ashley Van Zeeland, Ph.D

Advisor, CTO at Human Longevity, Co-Founder Cypher Genomics

Luna DNA LinkedIn
Carlos Bustamante, Ph.D

Carlos Bustamante, Ph.D

Advisor, Professor of Biomedical Data Science and Genetics at Stanford University

Luna DNA LinkedIn
Aristides A.N. Patrinos, Ph.D

Aristides A.N. Patrinos, Ph.D

Advisor, Former President Synthetic Genomics, Lead at Human Genome Project

Luna DNA LinkedIn
Sharon Terry

Sharon Terry

Advisor, CEO at Genetic Alliance, Chair of the Coalition for Genetic Fairness

Luna DNA LinkedIn
David Barker, Ph.D

David Barker, Ph.D

Advisor, Former Chief Scientific Officer of Illumina

Luna DNA LinkedIn
Francisco Garcia, Ph.D

Francisco Garcia, Ph.D

Advisor, VP Software Engineering at Illumina

Luna DNA LinkedIn
Ed Yu

Ed Yu

Advisor, Chairman of Vascular Cures, Former partner at PwC Strategy & Healthcare

Luna DNA LinkedIn
Alex Casdin

Alex Casdin

Advisor, Founder & CEO of Reneo Capital healthcare fund; former VP Amylin Pharmaceuticals

Luna DNA LinkedIn

Investors

Luna DNA is backed by leading healthcare and technology investors including:

Luna DNA Team

Illumina Ventures

Biotech VC Fund

Luna DNA Team

Arch Venture Partners

Biotech VC Fund

Luna DNA Team

Hemispshere Ventures

Future-Tech VC Fund

Luna DNA Team

Bridgelink Capital

UK Tech VC Fund

Luna DNA Team

Gavin Saitowitz

CEO of Prelude Capital

Luna DNA Team

David Walt

Co-Founder of Illumina